Filtered By:
Cancer: Liver Cancer
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 31222 results found since Jan 2013.
Usefulness of tumor perfusion on cone-beam CT after hepatic arterial infusion port implantation for evaluating tumor response to hepatic arterial infusion chemotherapy in hepatocellular carcinoma treatment
CONCLUSION: Hyperperfusion tumors on CBCT showed a better tumor response to HAIC, with a 65% ORR in patients with HCC. Tumor perfusion on CBCT after implantation of the hepatic arterial infusion port was associated with the tumor response to HAIC.PMID:37695260 | DOI:10.4274/dir.2023.232311
Source: Diagnostic and Interventional Radiology - September 11, 2023 Category: Radiology Authors: Phan Nhan Hien Ho Jong Chun Jung Suk Oh Su Ho Kim Byung Gil Choi Source Type: research
Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up
Am J Trop Med Hyg. 2023 Sep 11:tpmd230236. doi: 10.4269/ajtmh.23-0236. Online ahead of print.ABSTRACTThere is a lack of real-world data on hepatitis B (HBV) treatment in Africa. We conducted a single-center 18-month prospective cohort study in Ethiopia to understand clinical, laboratory, and demographic variables associated with HBV treatment. One hundred fifty HBV-positive patients were included: 51 on treatment, 99 with no treatment. Median age was similar between groups. Those on treatment were more likely to be male (86%), report higher coffee intake (90% versus 70%, P < 0.05), lower khat intake (0% versus 9%, P = 0...
Source: Am J Trop Med Hyg - September 11, 2023 Category: Infectious Diseases Authors: Manaswita Tappata Marina Farah Chimaobi Anugwom Eden Bisrat Amir S Seid Jose D Debes Source Type: research
Usefulness of tumor perfusion on cone-beam CT after hepatic arterial infusion port implantation for evaluating tumor response to hepatic arterial infusion chemotherapy in hepatocellular carcinoma treatment
CONCLUSION: Hyperperfusion tumors on CBCT showed a better tumor response to HAIC, with a 65% ORR in patients with HCC. Tumor perfusion on CBCT after implantation of the hepatic arterial infusion port was associated with the tumor response to HAIC.PMID:37695260 | DOI:10.4274/dir.2023.232311
Source: Diagnostic and Interventional Radiology : The Turkish Society of Radiology - September 11, 2023 Category: Radiology Authors: Phan Nhan Hien Ho Jong Chun Jung Suk Oh Su Ho Kim Byung Gil Choi Source Type: research
Siparuna guianensis essential oil antitumoral activity on Ehrlich model and its effect on oxidative stress
Chem Biodivers. 2023 Sep 10:e202301120. doi: 10.1002/cbdv.202301120. Online ahead of print.ABSTRACTThis work aims to evaluate the chemical composition, in vitro antioxidant capacity, and in vivo antitumoral activity of S. guianensis essential oil against Ehrlich's ascitic carcinoma and the effects on oxidative stress. The animals (Mus musculus) received a daily dose of S. guianensis oil orally (100 mg/kg) for 9 days. The main constituents of essential oil were curzerenone (16.4±1.5%), drimenol (13.7±0.2%), and spathulenol (12.4±0.8%). S. guianensis oil showed antioxidant activity, inhibiting 11.1% of DPPH radicals (95.7...
Source: Chemistry and Biodiversity - September 10, 2023 Category: Biochemistry Authors: Lucas Gabriel Viana Barbosa Ellen Nayara Silva de Jesus Lucas Botelho Jer ônimo Jamile Silva da Costa Renata Cunha Silva William N Setzer Joyce Kelly R da Silva Jofre Jacob da Silva Freitas Pablo Luis Figueiredo Source Type: research
Prognostic value and immunological role of CSNK1D in human cancers
In conclusion, this study suggests that CSNK1D may serve as a biomarker for tumor prognosis and immunotherapy. It influences the proliferation and metastasis of HCC cells.PMID:37688771 | DOI:10.18632/aging.205009
Source: Aging - September 9, 2023 Category: Biomedical Science Authors: Jianguo Wang Baohong Hu Weixing Wang Source Type: research
A comprehensive survival and prognosis analysis of GPR55 expression in hepatocellular carcinoma
Aging (Albany NY). 2023 Sep 8;15. doi: 10.18632/aging.205008. Online ahead of print.ABSTRACTHepatocellular carcinoma (HCC) is the most common subtype, accounting for about 90% of all primary liver cancers. The liver is rich in a large number of immune cells, thus forming a special immune microenvironment, which plays a key role in the occurrence and development of hepatocellular carcinoma. Nowadays, tumor immunotherapy has become one of the most promising cancer treatment methods. Immune checkpoint inhibitors (ICIs) combined with VEGF inhibitors are listed as first-line treatment options for advanced HCC. Therefore, the se...
Source: Aging - September 9, 2023 Category: Biomedical Science Authors: Tianyu Wang Kang Xia Tao Qiu Shangting Han Zhongbao Chen Xiaoxiong Ma Long Zhang Jilin Zou Yalong Zhang Bo Yu Chenyang Kong Jiayu Guo Yiting Liu Jiangqiao Zhou Shusen Zheng Source Type: research
Recent advances in natural polysaccharides against hepatocellular carcinoma: A review
Int J Biol Macromol. 2023 Sep 7:126766. doi: 10.1016/j.ijbiomac.2023.126766. Online ahead of print.ABSTRACTHepatocellular carcinoma (HCC) is a malignant tumor of the digestive system that poses a serious threat to human life and health. Chemotherapeutic drugs commonly used in the clinic have limited efficacy and heavy adverse effects. Therefore, it is imperative to find effective and safe alternatives, and natural polysaccharides (NPs) fit the bill. This paper summarizes in detail the anti-HCC activity of NPs in vitro, animal and clinical trials. Furthermore, the addition of NPs can reduce the deleterious effects of chemot...
Source: International Journal of Biological Macromolecules - September 9, 2023 Category: Biochemistry Authors: Dazhen Wang Zhengfeng Zhang Lu Zhao Liu Yang ChangJie Lou Source Type: research
Use of Near-Infrared Fluorescence Techniques in Minimally Invasive Surgery for Colorectal Liver Metastases
In this study, we present a comprehensive literature review of the existing literature pertaining to intraoperative fluorescence imaging in minimally invasive surgery for CRLM. Moreover, our analysis places specific emphasis on the techniques employed in liver resection using ICG, with a focus on tumour detection in minimal invasive surgery (MIS). Additionally, we delve into recent developments in this field and offer insights into future perspectives for further advancements.PMID:37685603 | PMC:PMC10488819 | DOI:10.3390/jcm12175536
Source: Clinical Colorectal Cancer - September 9, 2023 Category: Cancer & Oncology Authors: Ishaan Patel Saad Rehman Siobhan McKay David Bartlett Darius Mirza Source Type: research
Prognostic value and immunological role of CSNK1D in human cancers
In conclusion, this study suggests that CSNK1D may serve as a biomarker for tumor prognosis and immunotherapy. It influences the proliferation and metastasis of HCC cells.PMID:37688771 | DOI:10.18632/aging.205009
Source: Aging - September 9, 2023 Category: Biomedical Science Authors: Jianguo Wang Baohong Hu Weixing Wang Source Type: research
A comprehensive survival and prognosis analysis of GPR55 expression in hepatocellular carcinoma
Aging (Albany NY). 2023 Sep 8;15. doi: 10.18632/aging.205008. Online ahead of print.ABSTRACTHepatocellular carcinoma (HCC) is the most common subtype, accounting for about 90% of all primary liver cancers. The liver is rich in a large number of immune cells, thus forming a special immune microenvironment, which plays a key role in the occurrence and development of hepatocellular carcinoma. Nowadays, tumor immunotherapy has become one of the most promising cancer treatment methods. Immune checkpoint inhibitors (ICIs) combined with VEGF inhibitors are listed as first-line treatment options for advanced HCC. Therefore, the se...
Source: Aging - September 9, 2023 Category: Biomedical Science Authors: Tianyu Wang Kang Xia Tao Qiu Shangting Han Zhongbao Chen Xiaoxiong Ma Long Zhang Jilin Zou Yalong Zhang Bo Yu Chenyang Kong Jiayu Guo Yiting Liu Jiangqiao Zhou Shusen Zheng Source Type: research
Use of Near-Infrared Fluorescence Techniques in Minimally Invasive Surgery for Colorectal Liver Metastases
In this study, we present a comprehensive literature review of the existing literature pertaining to intraoperative fluorescence imaging in minimally invasive surgery for CRLM. Moreover, our analysis places specific emphasis on the techniques employed in liver resection using ICG, with a focus on tumour detection in minimal invasive surgery (MIS). Additionally, we delve into recent developments in this field and offer insights into future perspectives for further advancements.PMID:37685603 | DOI:10.3390/jcm12175536
Source: Clinical Colorectal Cancer - September 9, 2023 Category: Cancer & Oncology Authors: Ishaan Patel Saad Rehman Siobhan McKay David Bartlett Darius Mirza Source Type: research
Recent advances in natural polysaccharides against hepatocellular carcinoma: A review
Int J Biol Macromol. 2023 Sep 7:126766. doi: 10.1016/j.ijbiomac.2023.126766. Online ahead of print.ABSTRACTHepatocellular carcinoma (HCC) is a malignant tumor of the digestive system that poses a serious threat to human life and health. Chemotherapeutic drugs commonly used in the clinic have limited efficacy and heavy adverse effects. Therefore, it is imperative to find effective and safe alternatives, and natural polysaccharides (NPs) fit the bill. This paper summarizes in detail the anti-HCC activity of NPs in vitro, animal and clinical trials. Furthermore, the addition of NPs can reduce the deleterious effects of chemot...
Source: International Journal of Biological Macromolecules - September 9, 2023 Category: Biochemistry Authors: Dazhen Wang Zhengfeng Zhang Lu Zhao Liu Yang ChangJie Lou Source Type: research
Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
EClinicalMedicine. 2023 Aug 30;63:102179. doi: 10.1016/j.eclinm.2023.102179. eCollection 2023 Sep.ABSTRACTBACKGROUND: Atezolizumab-bevacizumab (atezo-bev) is recommended as first-line therapy for patients with unresectable hepatocellular carcinoma (uHCC). However, its effectiveness and safety in other populations, including those with Child-Turcotte-Pugh (CTP) class B cirrhosis, is unclear.METHODS: For this systematic review and meta-analysis, electronic databases, including PubMed, Embase, and Scopus, were searched from 1st May, 2020 till 5th October, 2022; the last date of access was January 31, 2023. Pooled progression-...
Source: Cancer Control - September 8, 2023 Category: Cancer & Oncology Authors: Anand V Kulkarni Harshvardhan Tevethia Karan Kumar Madhumita Premkumar Mark D Muttaiah Atsushi Hiraoka Takeshi Hatanaka Toshifumi Tada Takashi Kumada Satoru Kakizaki Arndt Vogel Richard S Finn Padaki Nagaraja Rao Anjana Pillai Duvvur Nageshwar Reddy Amit Source Type: research
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial
This study was funded by CARsgen Therapeutics Co., Ltd.PMID:37680942 | PMC:PMC10480529 | DOI:10.1016/j.eclinm.2023.102175
Source: Cancer Control - September 8, 2023 Category: Cancer & Oncology Authors: Qihan Fu Yi Zheng Weijia Fang Qingwei Zhao Peng Zhao Lulu Liu You Zhai Zhou Tong Hangyu Zhang Meihua Lin Xudong Zhu Huamao Wang Yumeng Wang Zhen Liu Daijing Yuan Xuanwen Bao Wanwan Gao Xiaomeng Dai Zonghai Li Tingbo Liang Source Type: research
